Signaturefd, LLC Kinnate Biopharma Inc. Transaction History

Signaturefd, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	SELL	$5.26 - $12.19 $4,449 - $10,312	-846 Reduced 87.67%	119 $0
Q3 2022 Nov 08, 2022	BUY	$9.86 - $15.76 $1,548 - $2,474	157 Added 19.43%	965 $12,000
Q2 2022 Aug 10, 2022	SELL	$7.43 - $13.0 $3,484 - $6,097	-469 Reduced 36.73%	808 $10,000
Q1 2022 May 02, 2022	BUY	$7.73 - $17.99 $8,302 - $19,321	1,074 Added 529.06%	1,277 $14,000
Q4 2021 Jan 25, 2022	SELL	$16.5 - $25.48 $264 - $407	-16 Reduced 7.31%	203 $4,000
Q3 2021 Oct 28, 2021	BUY	$17.81 - $24.87 $2,849 - $3,979	160 Added 271.19%	219 $5,000
Q2 2021 Jul 26, 2021	BUY	$22.19 - $31.55 $1,309 - $1,861	59 New	59 $1,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.